T he osteopontin (Opn) glycoprotein has been independently identified and studied by investigators from numerous scientific fields in view of its role in immune responses, vascularization, and bone formation through interactions with mononuclear, endothelial, and bone cells, respectively. Analysis of its contribution to immune responses has suggested that Opn expression can set the stage for protective type-1 immune responses after viral and bacterial infection through differential regulation of IL-12 and IL-10 cytokine production (1) (2) (3) .
Studies of Opn-deficient (Opn Ϫ/Ϫ ) mice have indicated that Opn contributes to host resistance against diverse microbial pathogens including herpes simplex virus 1, Listeria monocytogenes (4) , and rotavirus (5) . Opn expression is also essential for effective Th1-dependent granuloma formation and a positive clinical outcome in patients suffering from mycobacterial infection (6) , whereas ectopic Opn expression has been implicated in the granulomatous lesions of Crohn's disease (7) . Dysregulated Opn expression has also been implicated in several autoimmune disorders, including murine experimental autoimmune encephalomyelitis (EAE) (8, 9) , multiple sclerosis (10) , rheumatoid arthritis (11) , and atherosclerosis (12, 13) . Dysregulated Opn expression has been correlated with excessive Th1 polarization of CD4 ϩ T cells in these disorders (7, 14) opening the possibility that Opn gene expression may directly contribute to Th1͞type 1 CD8 ϩ T cells (Tc1) genetic programming. However, the genetic basis of Opn expression in Th-cell subsets is not well understood.
T-bet, a member of the T box family of transcription factors, is the master coordinator of gene expression in T cells that initiate type-1 immunity and is essential for Th1 cell polarization (15) . Thus, T-bet deficiency reduces IFN-␥ production by activated CD4 ϩ T cells and T cell antigen receptor (TCR)-transgenic CD8 ϩ T cells (OT-1) (16, 17) . The rapid and specific induction of T-bet in developing Th1 but not in Th2 cells (15) is controlled by signals from the T cell receptor and the IFN-␥ receptor͞signal transducer and activator of transcription 1 transduction pathways (18, 19) . The factors that contribute to the Th1 developmental pathway are broadly divisible into T-bet-dependent and T-bet-independent components. T-bet-dependent elements of the Th1 pathway include IFN-␥ and IL-12 receptor ␤2, whereas T-bet-independent elements include IL-7, IL-15, IL-21, and IL-18. Although there is increasing evidence that Opn promotes Th1-dependent immune responses, we do not know whether Opn belongs to the T-bet-dependent or -independent component of this process. Here we investigate the potential role of T-bet in regulating Opn gene expression in activated T cells and macrophages. We find that Opn expression represents a unique aspect of the T-bet-dependent genetic pathway to type-1 immunity.
Materials and Methods
Animals and Reagents. Opn-deficient mice have been backcrossed onto B6 and BALB͞c mice at least to 10 generations. T-betdeficient (T-bet Ϫ/Ϫ ) mice have been backcrossed onto either B6 or BALB͞c for seven generations. B6 2D2 transgenic mice were a gift from V. K. Kuchroo (Harvard Medical School). B6 Rag2 Ϫ/Ϫ and B6 OT-1 mice were obtained from The Jackson Laboratory. Opn promoter-luciferase construct (pXP2) was a gift from D. Denhardt (Rutgers University, Piscataway, NJ). Recombinant mouse cytokines were purchased from Pharmingen. IFN-␥ bioactivity was confirmed by a previously described method (20) . Myelin oligodendrocyte glycoprotein (MOG) (residues 35-55) peptide (MEVGWYRSPFSRVVHLYRNGK) and OT-1 peptide (SIIN-FEKL) were synthesized at New England Peptide, Gardner, MA.
Cell Purification and Tissue Culture. T cells were purified by magnetic beads selection as described in ref. 9 . In brief, single-cell suspensions were obtained, and cells were suspended in labeling buffer (2% FBS in PBS) at a concentration of 10 7 cells per ml. To purify total T cells, 10 g͞ml purified rat mAb for anti-B220 as well as anti-CD11b, anti-GR-1, and anti-NK1.1 or anti-DX5 (Pharmingen), each at 5 g͞ml, were incubated with the cells for 30 min at 4°C. For CD4 ϩ and CD8 ϩ T cell purification, anti-CD8␣ and anti-CD4 Abs, respectively, were added to the previously described Ab mixture. After being incubated and washed, Ab-bound cells were incubated with 50 l͞ml Dynabeads M-450 sheep anti-rat IgG (Dynal, Great Neck, NY) followed by magnetic separation. Cell purity was Ͼ90% as judged by enumeration of CD3 ϩ CD4 ϩ and CD3 ϩ CD8 ϩ cells by flow cytometry. Positive selection of dendritic cells (DCs), CD4
ϩ , and CD8 ϩ T cells was carried out by using anti-CD11c, anti-CD4, or anti-CD8 MiniMacs beads (Miltenyi), respectively, according to the manufacturer's protocol. For peritoneal macrophage preparation, mice were i.p. injected with 1 ml of 3% thioglycollate (Sigma). Four days later, cells were harvested by peritoneal lavage using ice-cold PBS followed by plastic adherence for 1 h at 37°C, followed by washing three times with complete medium at 37°C. Adherent cells were removed from the plates by using Cell Stripper solution (Mediatech, Washington, DC) and were Ͼ95% positive for macrophage marker F4͞80 staining. Complete medium consisted of RPMI medium 1640 supplemented with 10% FBS (Sigma), L-glutamine, 2-mercaptoethanol, and penicillin͞ streptomycin. Anti-CD3 Ab with or without anti-CD28 Ab were coated onto plates by incubating purified Abs at the indicated concentrations for overnight at 4°C. Plates were washed three times with 1ϫ PBS before cells were plated.
T-Bet Retroviral Transduction. The GFP-RV-T-bet (RV, retrovirus) was constructed by inserting T-bet cDNA into GFP-RV bicistronic vector (15) . The Phoenix-Eco packaging cell line was transfected as described in ref. 21 . Purified primary T cells were activated with plate-bound anti-CD3 and anti-CD28 Ab (1 g͞ml each). Later (24 h), cells were infected with RV in culture medium containing 8 g͞ml polybrene (Sigma). The T cell culture plates were centrifuged at 480 ϫ g for 45 min at room temperature. The medium was replaced 24 h after infection. Retrovirally transduced T cells were sorted by gating for GFP-positive cells and expanded until day 7 after primary activation. The cells were restimulated with platebound anti-CD3 Ab (1 g͞ml) for 24 h before harvesting the culture supernatants. As negative control, a GFP-RV mock vector lacking the T-bet gene was used.
ELISA Assays. All of the cytokine protein expression assays, with the exception of Opn, were carried out by using ELISA kits (Pharmingen or R & D Systems) according to the manufacturers' protocol. RNA͞cDNA Preparation and Real-Time PCR. After the cells were washed with PBS, total RNA was extracted from cells with an RNeasy kit (Qiagen, Valencia, CA). cDNA synthesis was initiated by priming total RNA with oligo(dT) and by reverse-transcribing with Moloney murine leukemia virus reverse transcription (Ambion, Austin, TX). Obtained cDNA was used for real-time PCR analyses on the Applied Biosystems 7700. QuantiTect SYBR Green PCR (Qiagen) was used to detect Opn and ␤-actin as an internal control. Opn primers were 5Ј-GCC TGT TTG GCA TTG CCT CCT C-3Ј (forward) and 5Ј-CAC AGC ATT CTG TGG CGC AAG G-3Ј (reverse). ␤-actin primers were 5Ј-TGT TAC CAA CTG GGA CGA CA-3Ј (forward) and 5Ј-CTG GGT CAT CTT TTC ACG GT-3Ј (reverse). Error bars indicate the maximum and minimum values calculated from SD and Ϫ⌬⌬Ct values of Opn and ␤-actin from triplicate PCR reactions as described in Applied Biosystems manuals. to 2 ϫ 10 9 units͞mg) of recombinant mouse IL-12 and 10 g͞ml anti-IL-4 Ab (Pharmingen). Th2͞Tc2 medium included 10 ng͞ml (0.25 ϫ 10 8 to 1 ϫ 10 8 units͞mg) of recombinant mouse IL-4 and 10 g͞ml each of anti-IFN-␥ and anti-IL-12 Abs (Pharmingen).
Luciferase Assay. The assay was carried out as described in ref. 15 . In brief, the Opn promoter (nucleotides Ϫ777 to ϩ79) vector fused with a luciferase gene was cotransfected into EL-4 cells with the following vectors by electroporation: T-bet expression vector, pCMV␤ (Clontech) vector expressing ␤-galactosidase as an internal control, and pcDNA vector (Invitrogen) as empty control to keep equal amounts of transfecting DNA among different samples. Luciferase activity was measured 48 h after transfection by using a luminometer. For indicated EL-4 cell samples, phorbol 12-myristate 13-acetate (50 ng͞ml) and ionomycin (500 ng͞ml) were added 24 h before cell harvest. Luciferase activity is shown as fold induction of the raw ''L͞G'' values [raw luciferase activity (as relative light units) normalized to raw ␤-galactosidase activity (relative light units)] of T-bet-transfected cells compared to the raw L͞G values of control vector-transfected cells.
Comparison of Opn mRNA and Secreted Protein Levels Between T Cells and Macrophages. T cells (CD4
ϩ and CD8 ϩ ) were purified from total spleen and lymph nodes (LNs). Macrophages were obtained by washing plate-bound peritoneal cells from mice injected with thioglycollate. T cells were seeded as 10 6 cells per ml on day 0 and activated with plate-bound 3 g͞ml anti-CD3 and 1 g͞ml anti-CD28 Abs. Nonactivated T cell samples were cultured in complete medium only. Macrophages were either activated with 30 ng͞ml of LPS or unactivated as 2 ϫ 10 6 cells per ml in complete medium. On day 5, live cells were selected and replated as 10 6 cells per ml for both T cells and macrophages. T cells previously activated were restimulated with plate-bound 3 g͞ml of anti-CD3 Ab. Macrophages previously stimulated with LPS were restimulated with the same concentration of LPS. Cells and culture supernatants were harvested 24 h after stimulation of T cells and macrophages. 
stimulation to prepare effector cells, responder and stimulator cells were mixed 1:1 and incubated with 10 units͞ml of IL-2 at 37°C for 7 d. Live cells were separated by density gradient by using NycoPrep 1.077 (Axis-Shield) and used for effector cells. As target cells, male splenocytes were stimulated with 5 g͞ml ConA for 2 d and used after density gradient with NycoPrep 1.077. Effector and target cells were incubated at indicated ratios for 4 h in phenol red-free complete RPMI medium 1640 (Life Technologies) supplied with 5% FCS, L-glutamine, 2-mercaptoethanol, and penicillin͞streptomycin. Cytotoxicity was evaluated by using CytoTox 96 nonradioactive cytotoxicity kit (Promega) by detecting lactose dehydrogenase release upon cell death. Reaction was carried out in quadruple wells.
Results

Opn Expression in T Cells Is Regulated by T-Bet.
Because expression of the transcription factor T-bet is essential to Th1 and Tc1 development (15, 16), we investigated its role in Opn gene expression in activated T cells. Four days after stimulation both CD4 ϩ T 
and CD8
ϩ T cells from B6 mice with plate-bound anti-CD3͞CD28 Ab in vitro, culture supernatants and T cells contained substantial levels of supernatant Opn protein and Opn mRNA, respectively (Fig. 1A) . Stimulation of T-bet-deficient T cells resulted in an approximate 5-fold reduction in Opn mRNA (Fig. 1B) and a 5-to 20-fold reduction of supernatant Opn in cultures of CD4 ϩ T and CD8 ϩ T cells (Fig. 1C) . Reduced Opn expression by T-bet-deficient cells did not reflect the need for an IFN-␥ intermediary, because provision of recombinant IFN-␥ did not restore production of Opn (Fig. 1D) . The T-bet dependence of Opn expression is congruent with the finding that Opn is overexpressed in Th1 cells and underexpressed in Th2 cells (Fig. 1E) . Moreover, T-bet-deficient CD4 ϩ T cells expressed markedly reduced Opn RNA and protein (Fig. 1E ) despite culture conditions that promote Th1 polarization (IL-12 plus anti-IL-4; see Materials and Methods), suggesting that Opn expression primarily depends on T-bet rather than Th1-polarizing conditions. The same conclusion was drawn with B6 (Th1-prone) or BALB͞c (Th2-prone) mice (data not shown).
Because diminished Opn expression by T cells from T-betdeficient donors might reflect T cell developmental defects, we asked whether acute reconstitution of T-bet expression in vitro might remedy defective Opn expression. Retroviral introduction of T-bet into T-bet-deficient CD4 ϩ T and CD8 ϩ T cells successfully reconstituted Opn expression at the mRNA and protein levels ( Fig.  2A) . Mutation of T-bet tyrosine Y525F reduces T-bet-dependent inhibitory activity for Th2 cytokines but has no effect on expression of the Th1 cytokine IFN-␥ (or IL-2) (22) . Analysis of the effects of transduction of T-bet-deficient CD4 ϩ T cells with RV-T-bet or RV-T-bet Y525F revealed that both RV-T-bet and RV-T-bet Y525F restored expression of the Th1 cytokine Opn (Fig. 2B) . Opn transactivation by T-bet was examined by using a vector containing the Opn promoter (nucleotides Ϫ777 to ϩ79) fused to a luciferase gene after transfection of EL-4 lymphoma cells with or without ectopic T-bet expression; the promoter activation was verified by luciferase activity. T-bet enhanced Opn promoter-driven luciferase activity by Ϸ2.5-fold with or without EL-4 cell activation by using phorbol 12-myristate 13-acetate͞ionomycin (Fig. 2C) , possibly reflecting cis-acting elements between Ϫ777 and ϩ 79 nt in the 5Ј region of the Opn gene.
To determine whether T-bet-dependent Opn gene expression is cell-type-specific, we evaluated Opn expression in T-bet-deficient DC and macrophages. T-bet ϩ/ϩ DC secreted 4-fold more Opn in 12-h culture supernatants than T-bet Ϫ/Ϫ DCs, suggesting that Opn expression by DC is at least partially dependent on T-bet (Fig. 3A) . In contrast, the T-bet genotype of macrophages did not affect Opn expression at either the mRNA or protein levels ( Fig. 3 B and C) .
Activated T Cells Are a Potent Source of Extracellular (Secreted) Opn
in Vitro and in Vivo. Unstimulated macrophages constitutively express high levels of Opn mRNA, which was not enhanced by LPS (Fig. 3D) . However, Opn secretion by macrophages is relatively modest compared with that of activated T cells (Fig. 3D) . The ratio of secreted Opn protein͞Opn mRNA of T cells at day 5 was at least 100-fold greater than that of LPS-activated macrophages (secreted Opn͞mRNA: T cells, 1,650 pg͞ml͞1 mRNA; macrophages, 180 pg͞ml͞15.6 mRNA), suggesting that activated T cells may use posttranslational mechanisms that allow more efficient Opn secretion compared to macrophages. Indeed, antigen-specific activation of 2D2 TCR transgenic CD4 ϩ T cells, reconstituted in Rag2 Ϫ/Ϫ mice, led to a 5-fold increase in serum Opn levels 5 d after stimulation with MOG peptide (Fig. 3E) , suggesting that activated T cells can play an important role in Opn levels during the immune responses in vivo.
Impact of Opn Deficiency on Th and Tc Responses.
We then investigated the potential impact of Opn deficiency on Th and Tc polarization. The IFN-␥͞IL-10 ratio of Opn-WT T cells was substantially higher than that of Opn-deficient cells with anti-CD3 activation (Fig. 4A) , whereas development of EAE in Opn-deficient mice was blunted (Fig. 4B) . The latter finding was based on disease intensity and incidence in B6 Opn-deficient mice generated after 16 generations of backcrossing to diminish the potential role of Opn-linked loci (23) before crossing with B6 2D2 TCR transgenic mice to allow a direct analysis of the CD4 ϩ T response to the autoantigenic MOG peptide. The T cell response of Opn-deficient 2D2 TCR-transgenic mice revealed a marked increase in IL-10 production and diminished IL-12 production (Fig. 4C) , suggesting that Opn expression is essential for promotion of robust Th1 responses. Opn deficiency did not affect 2D2 CD4 ϩ T cell proliferation (Fig. 4D) .
We next determined the impact of Opn on Tc1͞Tc2 responses. Opn-deficient CD8 ϩ T cells displayed enhanced IL-10 responses (but no obvious defect in IFN-␥ expression) with anti-CD3-dependent activation (Fig. 5 A and B) and with antigen-specific activation by using OT-1 peptide (Fig. 5C ). We then analyzed the impact of Opn deficiency on anti-HY CTL responses after female mice were primed and boosted with irradiated male splenocytes, followed by ex vivo stimulation with irradiated male splenocytes. Compared with Opn ϩ/ϩ cells, 10-fold more Opn-deficient cells were required to achieve the same level of anti-HY cytotoxicity (percentage) (Fig. 5D ).
Discussion
Opn is not a typical cytokine. Its activities are not confined to immune͞inflammatory responses, and it is expressed in many cell types in addition to hematopoietic cells. Because its initial biochemical characterization in bony tissues, experimental findings have emphasized the wide range of its effects on diverse physiological processes including wound healing, bone formation, inflammation, and more recently, immune responses. The impact of Opn on type-1 immunity reflects its expression by macrophages, DCs, and activated T cells. The Opn gene is constitutively expressed in macrophages in the absence of deliberate immunization, where it may regulate cellular activation and nitric oxide synthesis in response to bacterial and viral products (24) (25) (26) . In contrast, Opn gene expression in T cells is highly inducible upon signaling from the TCR (e.g., Fig. 1 A) . Although activator protein 1 and NF-B have been implicated in up-regulation of Opn gene transcription in macrophages (27) , the genetic basis of Opn expression in T cells and its role in T cell development is poorly understood. The studies presented here place the immunological role of Opn on a firmer genetic footing because they demonstrate the importance of the T-bet transcription factor in the induction of Opn gene expression and underline the importance of a T-bet-Opn axis in the events leading to Th1 and Tc1 polarization.
Opn reporter assays revealed that the Opn promoter region of nucleotides Ϫ777 to ϩ79 includes T-bet transactivation site(s).
Identification of the precise cis-acting element for T-bet binding in the ifng promoter has been difficult because of the possibility of multiple T-bet binding sites (28, 29) . We also searched for possible T-bet binding sequences in the Opn promoter based on the Brachyury elements suggested by Cho et al. (29) and Soutto et al. (28) , but the Opn promoter region of nucleotides Ϫ777 to ϩ79 does not include the typical Brachyury sequences. Absence of a typical Brachyury sequence in the Opn promoter may account for the rather modest Opn transactivation by ectopic T-bet expression (2-to 2.5-fold, Fig. 1D ) compared to a large degree of IFN-␥ transactivation (15) .
Macrophages express readily detectable Opn mRNA levels without overt stimulation and have been reported to represent the major cellular source of Opn. For example, although depletion of monocytes from cell culture reduced Opn levels after Penicillium marneffei stimulation, depletion of CD3 ϩ cells had little effect (25) . Although macrophages and other cellular components of the innate immune system express nonclonal receptors that allow quick and vigorous reactions to microbial stimuli, T cells require clonal expansion by specific antigen to produce significant Opn responses. However, once expanded, the remarkable inducibility of Opn secretion by activated T cells can account for a substantial portion of the Opn response in vivo (e.g., Fig. 3 D and E) . Our results that Opn-deficient 2D2 TCR transgenic mice displayed reduced development of EAE compared with Opn WT mice is consistent with the previous findings using non-TCR transgenic Opn-deficient mice backcrossed for six generations (8, 9) . The potential influence of genetic loci linked to Opn (23) is unlikely, because the mice used for this study underwent 16 generations of backcrossing to B6, i.e., the Opn gene is directly involved in EAE pathogenicity.
Expansion of the T-bet-driven genetic programming of Th1͞Tc1 cells to include Opn in addition to IFN-␥ and IL-12R␤2 provides an essential component of the cascade of genetic events that control T cell polarity after activation. However, our observations do not address the mechanism that translates Opn expression in Th1͞Tc1 development. Previous studies have suggested that engagement of Opn receptors on macrophages by recombinant Opn may induce IL-12 production and inhibit IL-10 production (4). These findings are consistent with this observation that immune responses of mice lacking Opn are marked by enhanced IL-10 production. However, this may not fully account for defective Th1͞Tc1 development of the mice because, for example, impaired development of CTL activity by Opn-deficient CD8 ϩ T cells is not remedied by provision of anti-IL-10 Ab or IL-12 (not shown), raising the possibility that the impact of Opn on Th1͞Tc1 development may include factors that have not yet been defined. 
